Catarina Edfjäll
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/03/2024
Profilo
Catarina Edfjäll formerly worked at The Cancer Drug Development Forum, as Director from 2008 to 2012, International Collaboration On Rare Diseases & Orphan Drugs, as Director from 2014 to 2021, ObsEva SA, as Independent Director from 2021 to 2024, and CSL Behring AG, as Global Head-Regulatory Affairs from 2013 to 2019.
Dr. Edfjäll received her doctorate degree from the University of Basel and graduate degree from the University of Strasbourg.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
OBSEVA SA
-.--% | 24/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Precedenti posizioni note di Catarina Edfjäll
| Società | Posizione | Fine |
|---|---|---|
| OBSEVA SA | Director/Board Member | 18/03/2024 |
| International Collaboration On Rare Diseases & Orphan Drugs | Director/Board Member | 01/01/2021 |
CSL Behring AG
 CSL Behring AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The private company is based in Bern, Switzerland. | General Counsel | 01/01/2019 |
| The Cancer Drug Development Forum | Director/Board Member | 01/01/2012 |
Formazione di Catarina Edfjäll
| University of Basel | Doctorate Degree |
| University of Strasbourg | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OBSEVA SA | Health Technology |
| Aziende private | 3 |
|---|---|
CSL Behring AG
CSL Behring AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The private company is based in Bern, Switzerland. | Health Technology |
| The Cancer Drug Development Forum | |
| International Collaboration On Rare Diseases & Orphan Drugs |
- Borsa valori
- Insiders
- Catarina Edfjäll
